Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer.

Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.

Br J Surg. 2013 Oct;100(11):1490-7. doi: 10.1002/bjs.9253.

PMID:
24037571
2.

Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.

Miyata H, Yamasaki M, Makino T, Tatsumi M, Miyazaki Y, Takahashi T, Kurokawa Y, Takiguchi S, Mori M, Doki Y.

Br J Surg. 2016 Jan;103(1):97-104. doi: 10.1002/bjs.9965. Epub 2015 Oct 27.

PMID:
26506079
3.

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.

Gillies RS, Middleton MR, Han C, Marshall RE, Maynard ND, Bradley KM, Gleeson FV.

Br J Surg. 2012 Feb;99(2):239-45.

PMID:
22329010
4.

Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.

Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y.

Ann Surg Oncol. 2015 Aug;22(8):2599-607. doi: 10.1245/s10434-014-4299-9. Epub 2014 Dec 19.

PMID:
25524011
5.

Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).

Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y.

Ann Surg Oncol. 2014 Feb;21(2):575-82. doi: 10.1245/s10434-013-3343-5. Epub 2013 Nov 8.

PMID:
24201746
6.

18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.

Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT.

J Nucl Med. 2004 Nov;45(11):1843-50.

7.

Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.

Kim SH, Lee KN, Kang EJ, Kim DW, Hong SH.

Br J Radiol. 2012 May;85(1013):606-12. doi: 10.1259/bjr/73516936. Epub 2011 Feb 8.

8.
9.

Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.

Yasuda T, Yano M, Miyata H, Yamasaki M, Higuchi I, Takiguchi S, Fujiwara Y, Doki Y.

Surg Today. 2015 Mar;45(3):335-45. doi: 10.1007/s00595-014-0956-7. Epub 2014 Jun 27.

PMID:
24969049
10.

Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.

Dalus K, Reitsamer R, Holzmannhofer J, Rendl G, Pirich C, Kronberger C, Rettenbacher L.

Nuklearmedizin. 2011;50(1):33-8. doi: 10.3413/nukmed-0320-10-05.

PMID:
21336417
11.

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

Flamen P, Van Cutsem E, Lerut A, Cambier JP, Haustermans K, Bormans G, De Leyn P, Van Raemdonck D, De Wever W, Ectors N, Maes A, Mortelmans L.

Ann Oncol. 2002 Mar;13(3):361-8.

PMID:
11996465
12.

Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.

Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Hervé JM, Botto H, Le Stanc E, Lebret T.

Eur J Surg Oncol. 2014 Dec;40(12):1724-30. doi: 10.1016/j.ejso.2014.08.479. Epub 2014 Sep 9.

PMID:
25242381
13.

[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.

Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha H, Schmidt M.

Ann Surg. 2009 Dec;250(6):888-94.

PMID:
19953708
14.

The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.

Yasuda T, Higuchi I, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Hatazawa J, Doki Y.

Ann Surg Oncol. 2012 Feb;19(2):652-60. doi: 10.1245/s10434-011-1928-4. Epub 2011 Jul 19.

PMID:
21769466
15.

The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.

Carlson ER, Schaefferkoetter J, Townsend D, McCoy JM, Campbell PD Jr, Long M.

J Oral Maxillofac Surg. 2013 Jan;71(1):162-77. doi: 10.1016/j.joms.2012.03.028. Epub 2012 Jun 26.

PMID:
22742956
16.

Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.

Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Ono CR, Lynn P, Bailão Aguilar P, Nahas SC, Gama-Rodrigues J, Buchpiguel CA.

Colorectal Dis. 2013 Jun;15(6):674-82. doi: 10.1111/codi.12159.

PMID:
23374979
17.

Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.

Ela Bella AJ, Zhang YR, Fan W, Luo KJ, Rong TH, Lin P, Yang H, Fu JH.

Chin J Cancer. 2014 Apr;33(4):211-7. doi: 10.5732/cjc.013.10039. Epub 2014 Feb 14.

18.

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.

Koolen BB, Valdés Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, Rutgers EJ.

Breast Cancer Res Treat. 2012 Aug;135(1):231-40. doi: 10.1007/s10549-012-2179-1. Epub 2012 Jul 28.

PMID:
22872522
19.

Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.

Kita Y, Okumura H, Uchikado Y, Sasaki K, Omoto I, Matsumoto M, Setoyama T, Tanoue K, Mori S, Owaki T, Ishigami S, Ueno S, Kajiya Y, Natsugoe S.

Ann Surg Oncol. 2013 May;20(5):1646-52. doi: 10.1245/s10434-012-2796-2. Epub 2012 Dec 13.

PMID:
23238695
20.

Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.

Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.

Int J Surg. 2007 Dec;5(6):399-403. Epub 2007 Jun 3.

Supplemental Content

Support Center